Patents by Inventor Peter H. King

Peter H. King has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Apparatus and method for vacuumizing and sealing a package
    Patent number: 11994237
    Abstract: An apparatus for vacuumizing and sealing a package includes a plurality of platens and vacuum chambers, each chamber adapted to mate with a dedicated one of the platens; a conveying system for conveying the platens and chambers along a generally angular path having a single axis of rotation; an automated loading assembly having a linear component and configured to load a package onto each of the platens; an automated unloading assembly having a linear portion and configured to unload a vacuumized, sealed package from each loaded platen onto an outfeed conveyor; and a vacuumizing/sealing system configured to cause relative movement of each chamber/platen pair, along a portion of the angular path, to form therebetween an air-tight enclosure accommodating the package and effect vacuumization and sealing of the package.
    Type: Grant
    Filed: June 28, 2023
    Date of Patent: May 28, 2024
    Assignees: Cryovac, LLC, Furukawa Mfg. Co., Ltd.
    Inventors: Gregory E. McDonald, Gregory H. Grossman, Joe A. Price, Rod Hodgson, John L. King, Jr., Shuichi Nakamoto, Yoshitaka Nii, Silvio Rohrer, Joel Caillier, Peter Schmalz
  • AMYOTROPHIC LATERAL SCLEROSIS (ALS) BIOMARKERS AND USES THEREOF
    Publication number: 20170248579
    Abstract: Provided herein are Amyotrophic lateral sclerosis (ALS) biomarkers and methods of using these ALS biomarkers to diagnose and treat ALS.
    Type: Application
    Filed: September 10, 2015
    Publication date: August 31, 2017
    Applicant: The UAB Research Foundation
    Inventor: Peter H. King
  • Methods and compositions involved in cell growth, neoplasia and immunoregulation
    Patent number: 5698427
    Abstract: A peptide, Hel-N1, which can bind to a 3'-untranslated mRNA sequence (which encompasses the "instability sequence") that is uniquely present in the messenger RNAs that encode oncoproteins and lymphokines, and mediates the specific destruction of the messenger RNAs, is described. Full-length Hel-N1 is capable of suppressing cell growth and causing cellular differentiation. Hel-N1 possess three RNA recognition motifs. One of these forms an RNA-binding domain which, when transfected alone into cells, causes them to undergo rapid growth.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: December 16, 1997
    Assignees: Jack D. Keene, Peter H. King, Todd Levine
    Inventors: Jack D. Keene, Peter H. King, Todd Levine
  • Methods and compositions useful in the recognition, binding and expression of ribonucleic acids involved in cell growth, neoplasia and immunoregulation
    Patent number: 5444149
    Abstract: A peptide, Hel-N1 (SEQ ID NO: 2), which can bind to a 3'-untranslated mRNA sequence (which encompasses the "instability sequence") that is uniquely present in the messenger RNAs that encode oncoproteins and lymphokines, and mediates the specific destruction of the messenger RNAs, is described. Full-length Hel-N1 is capable of suppressing cell growth and causing cellular differentiation. Hel-N1 (SEQ ID NO: 2) possess three RNA recognition motifs. One of these forms an RNA-binding domain which, when transfected alone into cells, causes them to undergo rapid growth.
    Type: Grant
    Filed: May 11, 1992
    Date of Patent: August 22, 1995
    Assignee: Duke University
    Inventors: Jack D. Keene, Peter H. King